Prateek Sharma, MD, FASGE, ASGE President

Dr. Prateek Sharma, MD

Claim this profile

Kansas City VA Hospital

Studies Acid Reflux
Studies Barrett's Esophagus
10 reported clinical trials
15 drugs studied

Affiliated Hospitals

Image of trial facility.
Kansas City VA Hospital
Image of trial facility.
Department Of Veterans Affairs Medical Center

Clinical Trials Prateek Sharma, MD is currently running

Image of trial facility.

Endoscopic Techniques

for Barrett's Esophagus

* The use of high resolution endoscopy (HRE), narrow band imaging (NBI) and chromoendoscopy increases the detection rates of Barrett's esophagus (BE) and early neoplasia. * Endoscopic mucosal resection (EMR) will improve the accuracy for detection of dysplasia/early neoplasia. Specific Aim 1 - To create a video-atlas of non-dysplastic and dysplastic/early neoplastic lesions in patients with BE. This will be used for training purposes and to assess learning curve associated with these new technologies. Specific Aim 2 - To create a standardized classification system for the mucosal and vascular patterns observed in patients with BE. Specific Aim 3 - To determine the interobserver agreement using the video-atlas for the mucosal and vascular patterns classification agreed upon. Specific Aim 4 - To determine the endoscopic detection rate of esophageal cancer or precancerous lesions removed during endoscopy. Specific Aim 5 - To determine the pathologic and clinical outcomes of patients undergoing EMR/ablation; including morbidity, mortality and complications of the procedure. Results to date (June 2008) : this study is active and open to enrollment. Currently 26 patients have enrolled in this study at the Kansas City VA medical center. In order to participate, patients must be eligible for care at the KCVA hospital.
Recruiting1 award N/A3 criteria
Image of trial facility.

Progression Study

for Barrett's Esophagus

The purpose of this study is to determine or evaluate the risk factors such as smoking, family history etc. that cause esophageal cancer and to determine the genetic changes that lead to esophageal cancer. The investigators hypothesis is that systematic collection of data on the natural history of GERD and BE patients and risk factors for development of BE in patients with chronic GERD and progression of BE to dysplasia and adenocarcinoma will provide useful information to develop a decision model for risk stratification and risk reduction strategies in these patients. As of March 17, 2011, 585 patients have consented at the Kansas City VA Medical Center.
Recruiting1 award N/A2 criteria

More about Prateek Sharma, MD

Clinical Trial Related2 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 2 Active Clinical Trials
Treatments Prateek Sharma, MD has experience with
  • ARAT
  • Sham Intervention (control)
  • Placebo
  • Esomeprazole
  • Secretrol
  • Chromoendoscopy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?
What does Prateek Sharma, MD specialize in?
Is Prateek Sharma, MD currently recruiting for clinical trials?
Are there any treatments that Prateek Sharma, MD has studied deeply?
What is the best way to schedule an appointment with Prateek Sharma, MD?
What is the office address of Prateek Sharma, MD?
Is there any support for travel costs?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security